ABBV · NYSE
AbbVie (ABBV) Stock Price & Fundamentals
AbbVie (ABBV) closed at $436.83 on Oct 9, 2026, down 0.44% from the previous close of $438.78.
Share price, past year
1Y +46.92%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $436.83 |
| Sep 30, 2026 | $441.44 |
| Aug 31, 2026 | $418.15 |
| Jul 31, 2026 | $379.85 |
| Jun 30, 2026 | $338.30 |
| May 29, 2026 | $319.55 |
| Apr 30, 2026 | $329.57 |
| Mar 31, 2026 | $325.29 |
| Feb 27, 2026 | $329.13 |
| Jan 30, 2026 | $325.95 |
| Dec 31, 2025 | $310.63 |
| Nov 28, 2025 | $296.92 |
| Oct 31, 2025 | $290.28 |
Key statistics
- Market cap
- $771.93B
- P/E (TTM)
- 123.4
- EPS (TTM)
- $3.54
- Revenue (TTM)
- $64.39B
- Net income (TTM)
- $6.31B
- Shares outstanding
- 1.8B
- Dividend yield
- 1.56%
- 52-week range
- $284.98 – $444.15
AbbVie's market cap is $771.93B, based on a share price of $436.83 and 1.8B shares outstanding as of Jul 27, 2026.
Financials
AbbVie reported revenue of $61.16B for fiscal 2025, up 8.57% from fiscal 2024.
AbbVie earned net income of $4.23B in fiscal 2025, a net margin of 6.9%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $61.16B | +8.6% | $4.23B | 6.9% | $2.36 | $17.82B |
| FY2024ended Dec 31, 2024 | $56.33B | +3.7% | $4.28B | 7.6% | $2.39 | $17.83B |
| FY2023ended Dec 31, 2023 | $54.32B | −6.4% | $4.86B | 9.0% | $2.72 | $22.06B |
| FY2022ended Dec 31, 2022 | $58.05B | +3.3% | $11.84B | 20.4% | $6.63 | $24.25B |
| FY2021ended Dec 31, 2021 | $56.20B | +22.7% | $11.54B | 20.5% | $6.45 | $21.99B |
| FY2020ended Dec 31, 2020 | $45.80B | +37.7% | $4.62B | 10.1% | $2.72 | $16.79B |
| FY2019ended Dec 31, 2019 | $33.27B | +1.6% | $7.88B | 23.7% | $5.28 | $12.77B |
| FY2018ended Dec 31, 2018 | $32.75B | +16.1% | $5.69B | 17.4% | $3.66 | $12.79B |
| FY2017ended Dec 31, 2017 | $28.22B | +10.1% | $5.31B | 18.8% | $3.30 | $9.43B |
| FY2016ended Dec 31, 2016 | $25.64B | — | $5.95B | 23.2% | $3.63 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $16.99B | $3.61B | $2.03 |
| Q1 FY2026ended Mar 31, 2026 | $15.00B | $695.00M | $0.39 |
| Q4 FY2025ended Dec 31, 2025 | $16.62B | $1.82B | $1.02 |
| Q3 FY2025ended Sep 30, 2025 | $15.78B | $186.00M | $0.10 |
| Q2 FY2025ended Jun 30, 2025 | $15.42B | $938.00M | $0.52 |
| Q1 FY2025ended Mar 31, 2025 | $13.34B | $1.29B | $0.72 |
| Q4 FY2024ended Dec 31, 2024 | $15.10B | −$22.00M | −$0.02 |
| Q3 FY2024ended Sep 30, 2024 | $14.46B | $1.56B | $0.88 |
Company profile
- Name
- AbbVie Inc.
- Ticker
- ABBV
- Exchange
- NYSE
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 1 North Waukegan Road, North Chicago, IL 60064
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001551152
Recent SEC filings
- Oct 5, 2026
- Sep 3, 2026
- Aug 18, 2026
- Aug 5, 2026
- Aug 3, 2026
- Jul 31, 2026
- Jul 6, 2026
- Jun 22, 2026
Frequently asked questions
What is AbbVie's stock price?
AbbVie (ABBV) closed at $436.83 on Oct 9, 2026, down 0.44% from the previous close of $438.78.
What is AbbVie's market cap?
AbbVie's market cap is $771.93B, based on a share price of $436.83 and 1.8B shares outstanding as of Jul 27, 2026.
How much revenue does AbbVie make?
AbbVie reported revenue of $61.16B for fiscal 2025, up 8.57% from fiscal 2024.
What is ABBV's P/E ratio?
AbbVie's price-to-earnings ratio is 123.4, based on trailing twelve-month diluted EPS of $3.54.
Does AbbVie pay a dividend?
Yes. AbbVie declared $6.83 per share in dividends over the last four quarters, a yield of 1.56%.
Sources and methodology
Fundamentals come from AbbVie Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures